---
title: "GLP-1s for Small Weight Loss: Best First Option?"
description: "GLP-1 medications aren’t always the best first choice for small weight loss. Learn when they’re appropriate and explore other options for modest weight loss."
url: "https://www.myalloy.com/knowledge-base/for-someone-with-only-a-small-amount-of-weight-to-lose-are-glp-1s-always-the-best-first-option"
---

# GLP-1s for Small Weight Loss: Best First Option?

> GLP-1 medications aren’t always the best first choice for small weight loss. Learn when they’re appropriate and explore other options for modest weight loss.

## For someone with only a small amount of weight to lose, are GLP-1s always the best first option?

Short answer, no, not always.

GLP-1 medications like Wegovy or Zepbound are intended for people with overweight or obesity, generally a BMI of 27 or higher, especially when there are other health risks involved. If someone only has 10 to 15 pounds to lose, they may not be the best first option.

In this conversation with Dr. Holly Lofton, she explains that these medications are designed to improve health and longevity, not just help with a small cosmetic weight loss goal. She also notes that BMI criteria matter when deciding who they’re appropriate for: [Tackling Midlife Weight Gain– Science, Support & Solutions | Dr. Holly Lofton & Liz Plosser - GLP-1s for Modest Weight Loss](https://www.youtube.com/watch?v=zKXybjEfQ0c&t=1969s)


[Watch video](https://www.youtube.com/watch?v=zKXybjEfQ0c&t=1969s)

In another discussion, it’s mentioned that for someone with about 10 pounds to lose, a GLP-1 might not be the right fit. There are also oral weight loss medications that could help someone “get over the hump,” depending on their health history and goals: [Navigating Weight Gain in Midlife: Hormones, Health, and Solutions | Liz Plosser & Dr. Disha Narang - Medication Options for Modest Weight Gain](https://www.youtube.com/watch?v=kBRBZbcbHH8&t=1631s)


[Watch video](https://www.youtube.com/watch?v=kBRBZbcbHH8&t=1631s)

At Alloy, we look at the whole picture. Your weight history, metabolic health, menopausal status, lifestyle habits, and any medical conditions all matter. For some women in midlife, even a modest amount of weight gain can come with increased visceral fat or changes in blood sugar and cholesterol. In that case, medication might be part of the plan. For others, focusing on strength training, protein intake, sleep, stress, or MHT adjustments may be the better first step.

If you’re curious whether GLP-1s make sense for you, our doctors can review your full health profile and talk through options, including whether medication or a different strategy is more appropriate: [Weight Care at Alloy](https://www.myalloy.com/weight)
[Weight Care at Alloy](https://www.myalloy.com/weight)

[Find Your Plan](https://secure.myalloy.com/experience)

---

This answer was created using the following resources:

- [Navigating Weight Gain in Midlife: Hormones, Health, and Solutions | Liz Plosser & Dr. Disha Narang - Medication Options for Modest Weight Gain](https://www.youtube.com/watch?v=kBRBZbcbHH8)
- [Tackling Midlife Weight Gain– Science, Support & Solutions | Dr. Holly Lofton & Liz Plosser - GLP-1s for Modest Weight Loss](https://www.youtube.com/watch?v=zKXybjEfQ0c)
- [Weight Care in Midlife | Dr. Corinne Menn - GLP-1 Effectiveness and Support](https://www.youtube.com/watch?v=yy2nssEtL8k)
- [How GLP-1s Support Weight Loss & Metabolic Health](https://www.myalloy.com/blog/how-do-glp-1s-work)
- [Are GLP-1 Weight Loss Medications Safe? | GLP-1 Side Effects](https://www.myalloy.com/blog/are-glp-1-medications-safe-and-what-about-side-effects)
- [Start Your Weight Care Journey with Alloy](https://www.myalloy.com/blog/starting-your-weight-care-journey)

---

*This is a markdown version of [https://www.myalloy.com/knowledge-base/for-someone-with-only-a-small-amount-of-weight-to-lose-are-glp-1s-always-the-best-first-option](https://www.myalloy.com/knowledge-base/for-someone-with-only-a-small-amount-of-weight-to-lose-are-glp-1s-always-the-best-first-option) for AI/LLM consumption.*